Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - AccuredReceivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Kura Oncology (KURA) Other Gross PP&E Adjustments (2022 - 2026)

Kura Oncology has reported Other Gross PP&E Adjustments over the past 5 years, most recently at $3.7 million for Q1 2026.

  • Quarterly Other Gross PP&E Adjustments rose 262.11% to $3.7 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $3.7 million through Mar 2026, up 262.11% year-over-year, with the annual reading at -$6.7 million for FY2025, 32.81% up from the prior year.
  • Other Gross PP&E Adjustments was $3.7 million for Q1 2026 at Kura Oncology, up from -$6.7 million in the prior quarter.
  • Over five years, Other Gross PP&E Adjustments peaked at $3.7 million in Q3 2025 and troughed at -$11.6 million in Q4 2023.
  • The 5-year median for Other Gross PP&E Adjustments is -$2.1 million (2024), against an average of -$2.6 million.
  • Year-over-year, Other Gross PP&E Adjustments plummeted 395.56% in 2024 and then skyrocketed 317.26% in 2025.
  • A 5-year view of Other Gross PP&E Adjustments shows it stood at -$6.3 million in 2022, then crashed by 84.63% to -$11.6 million in 2023, then grew by 14.7% to -$9.9 million in 2024, then surged by 32.81% to -$6.7 million in 2025, then skyrocketed by 155.33% to $3.7 million in 2026.
  • Per Business Quant, the three most recent readings for KURA's Other Gross PP&E Adjustments are $3.7 million (Q1 2026), -$6.7 million (Q4 2025), and $3.7 million (Q3 2025).